The target was one of the largest pharmaceutical factories in Sudan; Ellie Pharmaceuticals. SCLO represented Hikma Pharmaceuticals a LSE listed company.

SCLO's involvement in this transaction included the following:

• Forming a Sudanese private limited liability company (the purchaser) which is wholly owned by foreign companies;
• Rendering many legal opinions regarding some aspects of Sudanese investment law;
• Carrying out full legal due diligence-advice on registration of foreign capital in Central Bank;
• Advising on intellectual property specifically trademarks;
• Advising on corporate finance structure;
• Negotiating on behalf of the purchaser the terms of the SPA;
• Transferring of trade marks to the purchaser;
• Advising on the regulatory issues relevant to the Pharmaceutical industry in Sudan; and
• Transferring of title of land to the purchaser.